Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6QMB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,285
Award facts
- Contract value 100% obligated
- $46,284.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,284.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injections. The award, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., one of the nation's largest pharmaceutical distributors serving federal healthcare systems.
This delivery order falls under the broader DLA pharmaceutical supply framework, which supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The DLA Troop Support Medical maintains a significant $999.99 billion Indefinite Delivery Contract with Cencora, Inc. (through December 2031) to provide comprehensive pharmaceutical and medical supply support globally. Zepbound, a GLP-1 receptor agonist used primarily for weight management, represents the type of specialty pharmaceutical product that AmerisourceBergen routinely supplies through its federal contracts, which encompass diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F6QMB?
SPE2DR26F6QMB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F6QMB worth?
The government has obligated $46,285 on SPE2DR26F6QMB.
Is contract SPE2DR26F6QMB an order under another contract?
Yes. SPE2DR26F6QMB is a delivery order under SPE2DR25D3801, an indefinite delivery contract.
Was contract SPE2DR26F6QMB competed?
The extent of competition for SPE2DR26F6QMB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award